top of page
AdobeStock_352149697.jpeg

Multimodal chiropractic care for migraine: A pilot randomized controlled trial

Cite

Full Text Link

Randomized Controlled Trial

-

Structural and chiropractic

Cephalalgia.2021 Mar;41(3):318-328.

Authors:

P M Rist, C Bernstein, M Kowalski, K Osypiuk, J P Connor, R Vining, C R Long, E A Macklin, P M Wayne

Abstract.

Background: Spinal manipulation may reduce migraine frequency, but effects of multimodal chiropractic care on migraine frequency have not been evaluated. Methods: We conducted a pilot randomized controlled trial comparing multimodal chiropractic care + enhanced usual care (MCC+) versus enhanced usual care alone (EUC) among adult women with episodic migraine. EUC was comprised of usual medical care and migraine education literature. MCC+ participants received 10 sessions of chiropractic care over 14 weeks. Primary aims evaluated feasibility of recruitment, retention, protocol adherence, and safety. Change in migraine days was a secondary aim. Results: Of 422 patients screened, 61 were randomized over 20 months. Fifty-seven (93%) completed daily migraine logs during the intervention, 51 (84%) completed final follow-up, and 45 (74%) completed all assessments. Twenty-four of 29 MCC+ participants (83%) attended > 75% of the chiropractic sessions. Ninety-eight non-serious adverse events were reported by 26 participants (43%) with 39 events among 11 EUC participants and 59 events among 15 MCC+ participants. MCC+ participants experienced greater reductions in migraine days (-2.9 days for MCC+ vs. -1.0 days for EUC, difference = -1.9; 95% confidence interval: -3.5, -0.4). Conclusions: Pre-specified feasibility criteria were not met, but deficits were remediable. Preliminary data support a definitive trial of MCC+ for migraine.

Publication Date: 

2021 Mar

OEID: 

6087

Rist, MP., Bernstein, C., Kowalski, M., Osypiuk, K., Connor, PJ., Vining, R., Long, RC., Macklin, AE., Wayne, MP. (2021) 'Multimodal chiropractic care for migraine: A pilot randomized controlled trial', Cephalalgia.2021 Mar;41(3):318-328.

Sponsored by 

logo-footer-k.png

Search    Explore    About    Join    Web Policy     Contact Us

​

Copyright © 2023 OsteoEvidence. All Rights Reserved.
 

bottom of page